{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:34:35Z","timestamp":1792499675276,"version":"4.5.0"},"reference-count":60,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2023,3,21]]},"DOI":"10.18632\/oncotarget.28388","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T13:20:25Z","timestamp":1679404825000},"page":"219-235","source":"Crossref","is-referenced-by-count":10,"title":["Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior"],"prefix":"10.18632","volume":"14","author":[{"given":"Fang","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Experimental Medical Science, Glycobiology Group, Lund University, Biomedical Center A13, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Ch\u00e9rouvrier","family":"Hansson","sequence":"additional","affiliation":[{"name":"Department of Experimental Medical Science, Glycobiology Group, Lund University, Biomedical Center A13, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios","family":"Georgolopoulos","sequence":"additional","affiliation":[{"name":"Genevia Technologies Oy, Tampere 33100, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Mani","sequence":"additional","affiliation":[{"name":"Department of Experimental Medical Science, Glycobiology Group, Lund University, Biomedical Center A13, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186588","article-title":"Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment","volume":"2","author":"Pavone","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bcp.2019.06.020","article-title":"Role of glypicans in regulation of the tumor microenvironment and cancer progression","volume":"16","author":"Cummings","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"3","doi-asserted-by":"publisher","first-page":"569377","DOI":"10.3389\/fcell.2020.569377","article-title":"Proteoglycans as Mediators of Cancer Tissue Mechanics","volume":"8","author":"Weaver","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"4","doi-asserted-by":"publisher","first-page":"101189","DOI":"10.18632\/oncotarget.20516","article-title":"The clinical significance of circulating GPC1 positive exosomes and its regulative miRNAs in colon cancer patients","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.23736\/S2724-5985.21.03006-0","article-title":"Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma","volume":"6","author":"Saracco","year":"2022","journal-title":"Minerva Gastroenterol (Torino)"},{"key":"6","doi-asserted-by":"publisher","first-page":"1045995","DOI":"10.3389\/fonc.2022.1045995","article-title":"Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients","volume":"1","author":"Dechow","year":"2022","journal-title":"Front Oncol"},{"key":"7","doi-asserted-by":"publisher","first-page":"857308","DOI":"10.3389\/fimmu.2022.857308","article-title":"GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer","volume":"1","author":"Ren","year":"2022","journal-title":"Front Immunol"},{"key":"8","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1021\/acs.biochem.5b00653","article-title":"Decoding the Matrix: Instructive Roles of Proteoglycan Receptors","volume":"5","author":"Iozzo","year":"2015","journal-title":"Biochemistry"},{"key":"9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-3-030-40146-7_8","article-title":"The Role of Glypican-1 in the Tumour Microenvironment","volume":"124","author":"Walsh","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10","doi-asserted-by":"publisher","first-page":"C846","DOI":"10.1152\/ajpcell.00290.2021","article-title":"Role of glypican-1 in regulating multiple cellular signaling pathways","volume":"32","author":"Ho","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"11","doi-asserted-by":"publisher","first-page":"21934","DOI":"10.1074\/jbc.M701200200","article-title":"Heparan sulfate degradation products can associate with oxidized proteins and proteasomes","volume":"28","author":"Fransson","year":"2007","journal-title":"J Biol Chem"},{"key":"12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.yexcr.2017.03.021","article-title":"Nucleolin is a nuclear target of heparan sulfate derived from glypican-1","volume":"35","author":"Mani","year":"2017","journal-title":"Exp Cell Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"992929","DOI":"10.3389\/fonc.2022.992929","article-title":"Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma","volume":"1","author":"Huang","year":"2022","journal-title":"Front Oncol"},{"key":"14","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00432-021-03597-4","article-title":"Prognostic impact of the glypican family of heparan sulfate proteoglycans on the survival of breast cancer patients","volume":"14","author":"G\u00f6tte","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"15","doi-asserted-by":"publisher","first-page":"828","DOI":"10.18632\/oncotarget.27492","article-title":"Glypican-1 in human glioblastoma: implications in tumorigenesis and chemotherapy","volume":"1","author":"Toma","year":"2020","journal-title":"Oncotarget"},{"key":"16","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.21037\/jgo-22-240","article-title":"Glypican 1 promotes proliferation and migration in esophagogastric adenocarcinoma via activating AKT\/GSK\/\u03b2-catenin pathway","volume":"1","author":"Cohen","year":"2022","journal-title":"J Gastrointest Oncol"},{"key":"17","doi-asserted-by":"publisher","first-page":"8209700","DOI":"10.1155\/2022\/8209700","article-title":"GPC1 Is Associated with Poor Prognosis and Treg Infiltration in Colon Adenocarcinoma","volume":"202","author":"Li","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"18","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/modpathol.2017.190","article-title":"Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma","volume":"3","author":"Takeshima","year":"2018","journal-title":"Mod Pathol"},{"key":"19","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1186\/s12885-020-07562-1","article-title":"A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells","volume":"2","author":"Walsh","year":"2020","journal-title":"BMC Cancer"},{"key":"20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3892\/ol.2020.12058","article-title":"High glypican-1 expression is a prognostic factor for predicting a poor clinical prognosis in patients with hepatocellular carcinoma","volume":"2","author":"Wei","year":"2020","journal-title":"Oncol Lett"},{"key":"21","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/ijc.31124","article-title":"Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer","volume":"14","author":"Naka","year":"2018","journal-title":"Int J Cancer"},{"key":"22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.wneu.2017.05.165","article-title":"High Expression of Glypican-1 Predicts Dissemination and Poor Prognosis in Glioblastomas","volume":"10","author":"Kurisu","year":"2017","journal-title":"World Neurosurg"},{"key":"23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/bjc.2016.183","article-title":"Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma","volume":"11","author":"Kurokawa","year":"2016","journal-title":"Br J Cancer"},{"key":"24","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1002\/cam4.1833","article-title":"High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma","volume":"7","author":"Han","year":"2018","journal-title":"Cancer Med"},{"key":"25","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3892\/ol.2018.8701","article-title":"Prognostic value of glypican-1 for patients with advanced pancreatic cancer following regional intra-arterial chemotherapy","volume":"1","author":"Li","year":"2018","journal-title":"Oncol Lett"},{"key":"26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12943-017-0721-9","article-title":"Tumor-related interleukins: old validated targets for new anti-cancer drug development","volume":"1","author":"Xu","year":"2017","journal-title":"Mol Cancer"},{"key":"27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1152\/physiolgenomics.00158.2013","article-title":"The wound healing, chronic fibrosis, and cancer progression triad","volume":"4","author":"Cukierman","year":"2014","journal-title":"Physiol Genomics"},{"key":"28","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.3390\/ijms22105104","article-title":"Impaired Wound Healing, Fibrosis, and Cancer: The Paradigm of Recessive Dystrophic Epidermolysis Bullosa","volume":"2","author":"South","year":"2021","journal-title":"Int J Mol Sci"},{"key":"29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12967-019-2058-1","article-title":"The role of collagen in cancer: from bench to bedside","volume":"1","author":"Liu","year":"2019","journal-title":"J Transl Med"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Huang, Ge, Izzi, Greenspan. \u03b13 Chains of type V collagen regulate breast tumour growth via glypican-1. Nat Commun. 2017; 8:14351. https:\/\/doi.org\/10.1038\/ncomms14351.","DOI":"10.1038\/ncomms14351"},{"key":"31","doi-asserted-by":"publisher","first-page":"e12863","DOI":"10.1111\/sji.12863","article-title":"Interferon \u03b1 in cancer immunoediting: From elimination to escape","volume":"9","author":"Vidal","year":"2020","journal-title":"Scand J Immunol"},{"key":"32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-3-030-40146-7_7","article-title":"Heparan Sulfate in the Tumor Microenvironment","volume":"124","author":"Karousou","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"33","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3390\/diagnostics12071756","article-title":"Influence of S100A2 in Human Diseases","volume":"1","author":"Sawada","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/cancers10030079","article-title":"Erratum: Roche, J","volume":"1","author":"Roche","year":"2018","journal-title":"The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 2018, 10, 52. Cancers (Basel)"},{"key":"35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3109\/10715762.2013.821200","article-title":"p38 MAPK: a dual role in hepatocyte proliferation through reactive oxygen species","volume":"4","author":"Sastre","year":"2013","journal-title":"Free Radic Res"},{"key":"36","doi-asserted-by":"publisher","first-page":"109822","DOI":"10.1016\/j.cellsig.2020.109822","article-title":"Cell-surface heparan sulfate proteoglycans as multifunctional integrators of signaling in cancer","volume":"7","author":"G\u00f6tte","year":"2021","journal-title":"Cell Signal"},{"key":"37","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fonc.2019.00614","article-title":"The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer","volume":"9","author":"Bai","year":"2019","journal-title":"Front Oncol"},{"key":"38","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/iju.14683","article-title":"Glypican-1 as a target for fluorescence molecular imaging of bladder cancer","volume":"2","author":"Gillatt","year":"2021","journal-title":"Int J Urol"},{"key":"39","doi-asserted-by":"publisher","first-page":"17588359211022918","DOI":"10.1177\/17588359211022918","article-title":"Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target","volume":"1","author":"Gurney","year":"2021","journal-title":"Ther Adv Med Oncol"},{"key":"40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13550-020-00637-x","article-title":"Targeted beta therapy of prostate cancer withLu-labelled Miltuximabantibody against glypican-1 (GPC-1)","volume":"1","author":"Russell","year":"2020","journal-title":"EJNMMI Res"},{"key":"41","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1021\/acs.molpharmaceut.2c00760","article-title":"Pharmacokinetics and Biodistribution ofZr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma","volume":"2","author":"Thurecht","year":"2023","journal-title":"Mol Pharm"},{"key":"42","doi-asserted-by":"publisher","first-page":"14040","DOI":"10.1074\/jbc.M111.322487","article-title":"Crystal structure of N-glycosylated human glypican-1 core protein: structure of two loops evolutionarily conserved in vertebrate glypican-1","volume":"28","author":"Logan","year":"2012","journal-title":"J Biol Chem"},{"key":"43","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1107\/S0907444913025250","article-title":"Improvements in the order, isotropy and electron density of glypican-1 crystals by controlled dehydration","volume":"6","author":"Logan","year":"2013","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"44","doi-asserted-by":"publisher","first-page":"22991","DOI":"10.1074\/jbc.M115.660878","article-title":"Structural Aspects of N-Glycosylations and the C-terminal Region in Human Glypican-1","volume":"29","author":"Logan","year":"2015","journal-title":"J Biol Chem"},{"key":"45","doi-asserted-by":"publisher","first-page":"13323","DOI":"10.1038\/s41598-021-92725-8","article-title":"Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods","volume":"1","author":"Dhahbi","year":"2021","journal-title":"Sci Rep"},{"key":"46","first-page":"1139","article-title":"Correlation of glypican-1 expression with TGF-beta, BMP, and activin receptors in pancreatic ductal adenocarcinoma","volume":"2","author":"Friess","year":"2006","journal-title":"Int J Oncol"},{"key":"47","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.bbrc.2004.06.063","article-title":"Glypican-1 antisense transfection modulates TGF-beta-dependent signaling in Colo-357 pancreatic cancer cells","volume":"32","author":"Friess","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"48","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data","volume":"4","author":"Noushmehr","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"49","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.12688\/f1000research.8923.2","article-title":"TCGA Workflow: Analyze cancer genomics and epigenomics data using Bioconductor packages","volume":"5","author":"Noushmehr","year":"2016","journal-title":"F1000Res"},{"key":"50","doi-asserted-by":"publisher","first-page":"e1006701","DOI":"10.1371\/journal.pcbi.1006701","article-title":"New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx","volume":"1","author":"Papaleo","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"51","unstructured":"Therneau. A Package for Survival Analysis in R. R package version 3.2-7. 2020. https:\/\/CRAN.R-project.org\/package=survival."},{"key":"52","unstructured":"Kassambara, Kosinski, Biecek. survminer: Drawing Survival Curves using \u2018ggplot2\u2019. R package version 0.4.8. 2020. https:\/\/CRAN.R-project.org\/package=survminer."},{"key":"53","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"1","author":"Anders","year":"2014","journal-title":"Genome Biol"},{"key":"54","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"3","author":"Tugendreich","year":"2014","journal-title":"Bioinformatics"},{"key":"55","doi-asserted-by":"publisher","first-page":"47181","DOI":"10.1074\/jbc.M308325200","article-title":"Glypican-1 is a vehicle for polyamine uptake in mammalian cells: a pivital role for nitrosothiol-derived nitric oxide","volume":"27","author":"Fransson","year":"2003","journal-title":"J Biol Chem"},{"key":"56","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/j.1471-4159.2006.03981.x","article-title":"Copper-dependent co-internalization of the prion protein and glypican-1","volume":"9","author":"Mani","year":"2006","journal-title":"J Neurochem"},{"key":"57","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/glycob\/cwab126","article-title":"Complex modulation of cytokine-induced \u03b1-synuclein aggregation by glypican-1-derived heparan sulfate in neural cells","volume":"3","author":"Mani","year":"2022","journal-title":"Glycobiology"},{"key":"58","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/glycob\/10.6.577","article-title":"A novel role for nitric oxide in the endogenous degradation of heparan sulfate during recycling of glypican-1 in vascular endothelial cells","volume":"1","author":"Fransson","year":"2000","journal-title":"Glycobiology"},{"key":"59","doi-asserted-by":"publisher","first-page":"27559","DOI":"10.1074\/jbc.M111.243345","article-title":"Suppression of amyloid beta A11 antibody immunoreactivity by vitamin C: possible role of heparan sulfate oligosaccharides derived from glypican-1 by ascorbate-induced, nitric oxide (NO)-catalyzed degradation","volume":"28","author":"Mani","year":"2011","journal-title":"J Biol Chem"},{"key":"60","doi-asserted-by":"publisher","first-page":"14871","DOI":"10.1074\/jbc.M116.716829","article-title":"Xyloside-primed Chondroitin Sulfate\/Dermatan Sulfate from Breast Carcinoma Cells with a Defined Disaccharide Composition Has Cytotoxic Effects","volume":"29","author":"Mani","year":"2016","journal-title":"J Biol Chem"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T13:21:27Z","timestamp":1679404887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3,21]]}},"alternative-id":["28388"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.28388","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]}}}